137 related articles for article (PubMed ID: 30583616)
1. [Pathomechanisms of pericyte-myofibroblast transition in kidney and interventional effects of Chinese herbal medicine].
Liu YL; Shi G; Cao DW; Wan YG; Wu W; Tu Y; Liu BH; Han WB; Yao J
Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4192-4197. PubMed ID: 30583616
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
[TBL] [Abstract][Full Text] [Related]
3. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
Yang J; Wang M; Zhu F; Sun J; Xu H; Chong Lee Shin OL; Zhao Z; Pei G; Zhu H; Cao C; He X; Huang Y; Ma Z; Liu L; Wang L; Ning Y; Liu W; Xu G; Wang X; Zeng R; Yao Y
Stem Cell Res Ther; 2019 Mar; 10(1):104. PubMed ID: 30898157
[TBL] [Abstract][Full Text] [Related]
4. Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation.
Wang N; Deng Y; Liu A; Shen N; Wang W; Du X; Tang Q; Li S; Odeh Z; Wu T; Lin H
Sci Rep; 2017 Dec; 7(1):16914. PubMed ID: 29209018
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
6. Pericyte-myofibroblast transition in the human lung.
Yamaguchi M; Hirai S; Tanaka Y; Sumi T; Tada M; Takahashi H; Watanabe A; Sakuma Y
Biochem Biophys Res Commun; 2020 Jul; 528(2):269-275. PubMed ID: 32473754
[TBL] [Abstract][Full Text] [Related]
7. Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes.
Wang M; Xu H; Li Y; Cao C; Zhu H; Wang Y; Zhao Z; Pei G; Zhu F; Yang Q; Deng X; Zhou C; Guo Y; Wu J; Liao W; Yang J; Yao Y; Zeng R
Theranostics; 2020; 10(26):12144-12157. PubMed ID: 33204334
[No Abstract] [Full Text] [Related]
8. Bone Marrow-Derived Mesenchymal Stem Cells Transplantation Attenuates Renal Fibrosis Following Acute Kidney Injury in Rats by Diminishing Pericyte-Myofibroblast Transition and Extracellular Matrix Augment.
Wang H; Li M; Fei L; Xie C; Ding L; Zhu C; Zeng F; Liu N
Transplant Proc; 2023; 55(1):225-234. PubMed ID: 36604251
[TBL] [Abstract][Full Text] [Related]
9. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
Lin SL; Chang FC; Schrimpf C; Chen YT; Wu CF; Wu VC; Chiang WC; Kuhnert F; Kuo CJ; Chen YM; Wu KD; Tsai TJ; Duffield JS
Am J Pathol; 2011 Feb; 178(2):911-23. PubMed ID: 21281822
[TBL] [Abstract][Full Text] [Related]
10. Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling.
Castellano G; Franzin R; Stasi A; Divella C; Sallustio F; Pontrelli P; Lucarelli G; Battaglia M; Staffieri F; Crovace A; Stallone G; Seelen M; Daha MR; Grandaliano G; Gesualdo L
Front Immunol; 2018; 9():1002. PubMed ID: 29875766
[TBL] [Abstract][Full Text] [Related]
11. Shenkang injection, a modern preparation of Chinese patent medicine, diminishes tubulointerstitial fibrosis in obstructive nephropathy via targeting pericyte-myofibroblast transition.
Liu Y; Shi G; Yee H; Wang W; Han W; Liu B; Wu W; Tu Y; Ma Q; Huo D; Wan Z; Cao D; Wan Y
Am J Transl Res; 2019; 11(4):1980-1996. PubMed ID: 31105812
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of fibrosis: the role of the pericyte.
Schrimpf C; Duffield JS
Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
[TBL] [Abstract][Full Text] [Related]
13. LPS-Binding Protein Modulates Acute Renal Fibrosis by Inducing Pericyte-to-Myofibroblast Trans-Differentiation through TLR-4 Signaling.
Castellano G; Stasi A; Franzin R; Sallustio F; Divella C; Spinelli A; Netti GS; Fiaccadori E; Cantaluppi V; Crovace A; Staffieri F; Lacitignola L; Grandaliano G; Simone S; Pertosa GB; Gesualdo L
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357597
[TBL] [Abstract][Full Text] [Related]
14. Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway.
Wang YC; Chen Q; Luo JM; Nie J; Meng QH; Shuai W; Xie H; Xia JM; Wang H
Exp Mol Med; 2019 Mar; 51(3):1-11. PubMed ID: 30902967
[TBL] [Abstract][Full Text] [Related]
15. Regulation of pericyte metabolic reprogramming restricts the AKI to CKD transition.
Xu C; Hong Q; Zhuang K; Ren X; Cui S; Dong Z; Wang Q; Bai X; Chen X
Metabolism; 2023 Aug; 145():155592. PubMed ID: 37230215
[TBL] [Abstract][Full Text] [Related]
16. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.
Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS
J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366
[TBL] [Abstract][Full Text] [Related]
17. Pericyte activation accompanied by peritubular capillaries dysfunction and pericyte-to-myofibroblast transition is associated with renal fibrosis in diabetic nephropathy.
Feng Y; Tian D; Bai Y; Li Y; Zhang L; Wu Y; Liu W; Diao Z
Kidney Res Clin Pract; 2024 Feb; ():. PubMed ID: 38325871
[TBL] [Abstract][Full Text] [Related]
18. Small molecules against the origin and activation of myofibroblast for renal interstitial fibrosis therapy.
Feng YL; Wang WB; Ning Y; Chen H; Liu P
Biomed Pharmacother; 2021 Jul; 139():111386. PubMed ID: 34243594
[TBL] [Abstract][Full Text] [Related]
19. Kidney pericytes: a novel therapeutic target in interstitial fibrosis.
Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS
Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881
[TBL] [Abstract][Full Text] [Related]
20. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation.
Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ
Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
